- Home
- ZONE vs CVKD Comparison
ZONE vs CVKD Comparison
Compare ZONE & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZONE
- CVKD
- Stock Information
- Founded
- ZONE 2022
- CVKD 2022
- Country
- ZONE United States
- CVKD United States
- Employees
- ZONE N/A
- CVKD N/A
- Industry
- ZONE
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- ZONE
- CVKD Health Care
- Exchange
- ZONE NYSE
- CVKD Nasdaq
- Market Cap
- ZONE 19.3M
- CVKD 29.5M
- IPO Year
- ZONE 2024
- CVKD 2023
- Fundamental
- Price
- ZONE $4.04
- CVKD $10.54
- Analyst Decision
- ZONE
- CVKD Strong Buy
- Analyst Count
- ZONE 0
- CVKD 1
- Target Price
- ZONE N/A
- CVKD $32.00
- AVG Volume (30 Days)
- ZONE 57.0K
- CVKD 27.7K
- Earning Date
- ZONE 09-19-2025
- CVKD 08-11-2025
- Dividend Yield
- ZONE N/A
- CVKD N/A
- EPS Growth
- ZONE N/A
- CVKD N/A
- EPS
- ZONE N/A
- CVKD N/A
- Revenue
- ZONE $1,887,046.00
- CVKD N/A
- Revenue This Year
- ZONE N/A
- CVKD N/A
- Revenue Next Year
- ZONE N/A
- CVKD N/A
- P/E Ratio
- ZONE N/A
- CVKD N/A
- Revenue Growth
- ZONE 38.12
- CVKD N/A
- 52 Week Low
- ZONE $0.81
- CVKD $5.70
- 52 Week High
- ZONE $5.54
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- ZONE N/A
- CVKD 37.37
- Support Level
- ZONE N/A
- CVKD $11.25
- Resistance Level
- ZONE N/A
- CVKD $11.88
- Average True Range (ATR)
- ZONE 0.00
- CVKD 0.77
- MACD
- ZONE 0.00
- CVKD -0.03
- Stochastic Oscillator
- ZONE 0.00
- CVKD 2.95
About ZONE CLEANCORE SOLUTIONS INC
CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.